SUBMIT YOUR ABSTRACT FOR ASRM 2026
New analysis finds that PGT-P lacks proven clinical utility and raises significant scientific and ethical concerns
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward.
Gestational carrier (GC) care is a long-established, medically indicated specialized modality of assisted reproductive technology (ART).
ASRM's Center for Policy and Leadership (CPL) announced it's third class of the 2026 PRIMED cohort since the program’s 2024 beginning.
ASRM receives $1 M gift from Dr. Kwang‑Yul Cha to fund reproductive research grants — strengthening fertility science and innovation.
Third-party reproduction using a gestational carrier (GC) is a family-building option carried out in accordance with existing legal frameworks.
ASRM's Office of Public Affairs is running an Instagram campaign highlighting positive IVF stories featuring patients and providers.
IVF add-ons explained: costs, risks, and effectiveness. Learn what works, what doesn’t, and how to make informed fertility treatment decisions.
Endometriosis occurs when tissue similar to the uterine lining attaches to organs in the pelvis and begins to grow, leading to pain and infertility.
Uterine fibroids are noncancerous tumors in the uterus, also known as myomas or leiomyomas.
Displaying 601 to 610 of 1678 records
